Sign in
4

Changes in Ownership

Immix Biopharma, Inc. Filed Acc 0001493152-26-026430

Director acquired 6,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ng Carey Director 2026-05-22 Grant or award +6,250 26,250 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ng Carey Director 2026-05-22 Grant or award · Stock Option (Right to Buy) +12,500 12,500 D: show line 2 in the form
Loading xslF345X06/ownership.xml…